Journal article
Health-Related Quality of Life in Moderate Asthma 400 μg Hydrofluoroalkane Beclomethasone Dipropionate vs 800 μg Chlorofluorocarbon Beclomethasone Dipropionate
Abstract
OBJECTIVE: To compare the effect of hydrofluoroalkane-134a (HFA) beclomethasone dipropionate (BDP; 400 microg/d) with that of chlorofluorocarbon (CFC) BDP (800 microg/d) on asthma health-related quality of life in a 12-week, parallel-group, multicenter study.
BACKGROUND: HFA-BDP is a new CFC-free preparation of BDP, which was developed as a result of CFCs being phased out from metered dose inhalers.
Authors
Juniper EF; Buist AS; Group TS
Journal
CHEST Journal, Vol. 116, No. 5, pp. 1297–1303
Publisher
Elsevier
Publication Date
November 1999
DOI
10.1378/chest.116.5.1297
ISSN
0012-3692
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, InhalationAdolescentAdultAerosol PropellantsAgedAsthmaBeclomethasoneChlorofluorocarbonsDrug CombinationsFemaleForced Expiratory VolumeHealth StatusHumansHydrocarbons, FluorinatedMaleMiddle AgedPatient CompliancePeak Expiratory Flow RateQuality of LifeSafetySurveys and QuestionnairesTreatment Outcome